Cannabis stocks rally on Wall Street Journal report that Trump is weighing drug reclassification
1. Trump considers reclassifying marijuana from Schedule I to Schedule III. 2. Reclassification could boost investment and tax regulations for cannabis companies. 3. Stocks in the cannabis sector are currently undervalued at under $1 per share. 4. Bipartisan support exists for changing cannabis classification, a potential gamechanger. 5. Investors may gain early advantages before institutional capital enters the sector.